Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study

Circulating bilirubin, a natural antioxidant, is associated with decreased risk of type 2 diabetes (T2D), but the nature of the relationship remains unknown. We performed Mendelian randomization in a prospective cohort of 3,381 participants free of diabetes at baseline (age 28-75 years; women 52.6%)...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes (New York, N.Y.) Ročník 64; číslo 4; s. 1459
Hlavní autoři: Abbasi, Ali, Deetman, Petronella E, Corpeleijn, Eva, Gansevoort, Ron T, Gans, Rijk O B, Hillege, Hans L, van der Harst, Pim, Stolk, Ronald P, Navis, Gerjan, Alizadeh, Behrooz Z, Bakker, Stephan J L
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.04.2015
Témata:
Adult
Aged
Alleles
Bilirubin - blood
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - genetics
Female
Genetic Predisposition to Disease
Genotype
Glucuronosyltransferase - genetics
Humans
Male
Mendelian Randomization Analysis
Middle Aged
Polymorphism, Single Nucleotide
ISSN:1939-327X, 1939-327X
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Circulating bilirubin, a natural antioxidant, is associated with decreased risk of type 2 diabetes (T2D), but the nature of the relationship remains unknown. We performed Mendelian randomization in a prospective cohort of 3,381 participants free of diabetes at baseline (age 28-75 years; women 52.6%). We used rs6742078 located in the uridine diphosphate-glucuronosyltransferase locus as an instrumental variable (IV) to study a potential causal effect of serum total bilirubin level on T2D risk. T2D developed in a total of 210 participants (6.2%) during a median follow-up period of 7.8 years. In adjusted analyses, rs6742078, which explained 19.5% of bilirubin variation, was strongly associated with total bilirubin (a 0.68-SD increase in bilirubin levels per T allele; P < 1 × 10(-122)) and was also associated with T2D risk (odds ratio [OR] 0.69 [95% CI 0.54-0.90]; P = 0.006). Per 1-SD increase in log-transformed bilirubin levels, we observed a 25% (OR 0.75 [95% CI 0.62-0.92]; P = 0.004) lower risk of T2D. In Mendelian randomization analysis, the causal risk reduction for T2D was estimated to be 42% (causal OR for IV estimation per 1-SD increase in log-transformed bilirubin 0.58 [95% CI 0.39-0.84]; P = 0.005), which was comparable to the observational estimate (Durbin-Wu-Hausman χ(2) test, P for difference = 0.19). These novel results provide evidence that an elevated bilirubin level is causally associated with the risk of T2D and support its role as a protective determinant.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1939-327X
1939-327X
DOI:10.2337/db14-0228